These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


422 related items for PubMed ID: 15183323

  • 41. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
    Piras P, Roussel C.
    J Pharm Biomed Anal; 2008 Apr 14; 46(5):839-47. PubMed ID: 17942261
    [Abstract] [Full Text] [Related]

  • 42. Expanding the ChemGPS chemical space with natural products.
    Larsson J, Gottfries J, Bohlin L, Backlund A.
    J Nat Prod; 2005 Jul 14; 68(7):985-91. PubMed ID: 16038536
    [Abstract] [Full Text] [Related]

  • 43. Analysis of data fusion methods in virtual screening: similarity and group fusion.
    Whittle M, Gillet VJ, Willett P, Loesel J.
    J Chem Inf Model; 2006 Jul 14; 46(6):2206-19. PubMed ID: 17125165
    [Abstract] [Full Text] [Related]

  • 44. High-throughput characterization and quality control of small-molecule combinatorial libraries.
    Kenseth JR, Coldiron SJ.
    Curr Opin Chem Biol; 2004 Aug 14; 8(4):418-23. PubMed ID: 15288253
    [Abstract] [Full Text] [Related]

  • 45. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D, Baber JC, Feyfant E, Thompson DC, Humblet C.
    Curr Opin Drug Discov Devel; 2007 May 14; 10(3):264-74. PubMed ID: 17554852
    [Abstract] [Full Text] [Related]

  • 46. Integrating virtual screening in lead discovery.
    Oprea TI, Matter H.
    Curr Opin Chem Biol; 2004 Aug 14; 8(4):349-58. PubMed ID: 15288243
    [Abstract] [Full Text] [Related]

  • 47. Virtual screening - what does it give us?
    Köppen H.
    Curr Opin Drug Discov Devel; 2009 May 14; 12(3):397-407. PubMed ID: 19396741
    [Abstract] [Full Text] [Related]

  • 48. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A, Scheiber J, Glick M, Davies JW, Azzaoui K, Hamon J, Urban L, Whitebread S, Jenkins JL.
    ChemMedChem; 2007 Jun 14; 2(6):861-73. PubMed ID: 17477341
    [Abstract] [Full Text] [Related]

  • 49. Collection and preparation of molecular databases for virtual screening.
    Saxena AK, Prathipati P.
    SAR QSAR Environ Res; 2006 Aug 14; 17(4):371-92. PubMed ID: 16920660
    [Abstract] [Full Text] [Related]

  • 50. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.
    Blum LC, Reymond JL.
    J Am Chem Soc; 2009 Jul 01; 131(25):8732-3. PubMed ID: 19505099
    [Abstract] [Full Text] [Related]

  • 51. Assessment of structural diversity in combinatorial synthesis.
    Fergus S, Bender A, Spring DR.
    Curr Opin Chem Biol; 2005 Jun 01; 9(3):304-9. PubMed ID: 15939333
    [Abstract] [Full Text] [Related]

  • 52. When poor solubility becomes an issue: from early stage to proof of concept.
    Stegemann S, Leveiller F, Franchi D, de Jong H, Lindén H.
    Eur J Pharm Sci; 2007 Aug 01; 31(5):249-61. PubMed ID: 17616376
    [Abstract] [Full Text] [Related]

  • 53. Combinatorial biosynthesis for drug development.
    Menzella HG, Reeves CD.
    Curr Opin Microbiol; 2007 Jun 01; 10(3):238-45. PubMed ID: 17553731
    [Abstract] [Full Text] [Related]

  • 54. Drug- and lead-likeness, target class, and molecular diversity analysis of 7.9 million commercially available organic compounds provided by 29 suppliers.
    Chuprina A, Lukin O, Demoiseaux R, Buzko A, Shivanyuk A.
    J Chem Inf Model; 2010 Apr 26; 50(4):470-9. PubMed ID: 20297844
    [Abstract] [Full Text] [Related]

  • 55. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T, Baber JC, Feher M.
    J Chem Inf Model; 2006 Apr 26; 46(6):2423-31. PubMed ID: 17125184
    [Abstract] [Full Text] [Related]

  • 56. Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods.
    Houghten RA, Pinilla C, Giulianotti MA, Appel JR, Dooley CT, Nefzi A, Ostresh JM, Yu Y, Maggiora GM, Medina-Franco JL, Brunner D, Schneider J.
    J Comb Chem; 2008 Apr 26; 10(1):3-19. PubMed ID: 18067268
    [No Abstract] [Full Text] [Related]

  • 57. Development and virtual screening of target libraries.
    Rognan D.
    J Physiol Paris; 2006 Apr 26; 99(2-3):232-44. PubMed ID: 16459061
    [Abstract] [Full Text] [Related]

  • 58. Combinatorial chemistry in the agrosciences.
    Lindell SD, Pattenden LC, Shannon J.
    Bioorg Med Chem; 2009 Jun 15; 17(12):4035-46. PubMed ID: 19349185
    [Abstract] [Full Text] [Related]

  • 59. Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers.
    Monge A, Arrault A, Marot C, Morin-Allory L.
    Mol Divers; 2006 Aug 15; 10(3):389-403. PubMed ID: 17031540
    [Abstract] [Full Text] [Related]

  • 60. A kinase-focused compound collection: compilation and screening strategy.
    Sun D, Chuaqui C, Deng Z, Bowes S, Chin D, Singh J, Cullen P, Hankins G, Lee WC, Donnelly J, Friedman J, Josiah S.
    Chem Biol Drug Des; 2006 Jun 15; 67(6):385-94. PubMed ID: 16882313
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.